Crown Equity Holdings, Inc. (CRWE)
Online marketing has become the storefront process for many of the world’s largest companies. In this current climate of connectivity, any company without an online presence may as well not exist. To many, it is by far the most important part of their marketing strategy.
Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
The online advertising gives your ads a wider coverage and this globally wider coverage helps in making your advertisements reach more audiences, which may ultimately help you in getting better results through your online advertising campaign.
Another main advantage of online advertising or marketing is the much affordable price when compared with the traditional advertising costs. With a much lesser cost you can advertise on the net for a wider range of audience and geographical locations.
Crown Equity Holdings, Inc. has creative resources to dramatically enhance one’s company’s corporate identity with its in-house advertising and name-branding services. This includes creating, designing, implementing logos, and other strategies which rapidly increase one’s company’s credibility and value. As many people know, brand strength is a good indicator of the strength of a company and its financial value.
Crown Equity Holdings, Inc. together with its digital network currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.
Crown Equity Holdings, Inc.’s mission is to profitably disseminate a variety of information as a worldwide online media publisher in an environment that has a positive effect.
For more information about Crown Equity Holdings, Inc. visit its website
http://www.crownequityholdings.com
Power3 Medical Products, Inc (PWRME)
Breast cancer can have a number of symptoms but usually shows as a lump or thickening in the breast tissue (although most breast lumps are not cancerous). If cancer is detected at an early stage, it can be treated before it spreads to nearby parts of the body.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
There are several different types of breast cancer, which can develop in different parts of the breast. Breast cancer is often divided into non-invasive and invasive types.
Non-invasive breast cancer: Non-invasive breast cancer is also known as cancer or carcinoma in situ, or pre-cancerous cells.
Invasive breast cancer: Invasive cancer has the ability to spread outside the breast, although this does not mean it necessarily has spread. The most common form of breast cancer is invasive ductal breast cancer, which develops in the cells that line the breast ducts.
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of product NuroPro�, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
BC-SeraPro� is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro� test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com
ITT Corporation (NYSE:ITT) will release its first-quarter 2011 financial results at 7:00 a.m. EDT, Friday, April 29, 2011. At 9:00 a.m. EDT, senior management will review financial and operating results, comment on current conditions and answer questions during an investor briefing. The briefing can be monitored live by calling +1 (706) 643-7542 (ID#: 57668879) or at the following address on the company’s website: www.itt.com/investors. A replay of the briefing will be available on the website and telephonically until Friday, May 6, 2011 at 6:00 p.m. The telephone replay is available by calling +1 (706) 645-9291 (ID#: 57668879).
ITT Corporation designs, manufactures, and sells a range of engineered products, and provides related services worldwide. The company was founded in 1920 and is based in White Plains, New York.
Holly Corporation (NYSE:HOC) plans to announced results for the quarter ended March 31, 2011 on May 5, 2011, before the opening of trading on the NYSE. The company has scheduled a webcast conference on May 5, 2011 at 4:00PM Eastern time to discuss financial results. An audio archive of this webcast will be available using the above noted link through May 18, 2011.
Holly Corporation, together with its subsidiaries, operates as a petroleum refiner in the United States. Holly Corporation was founded in 1947 and is based in Dallas, Texas.
Invesco Mortgage Capital Inc. (NYSE:IVR) will announced its first quarter 2011 results on Tuesday, May 10, 2011 at 8:30 am ET. Scheduled to speak are Richard King, President and Chief Executive Officer; John Anzalone, Chief Investment Officer; and Donald Ramon, Chief Financial Officer.
Invesco Agency Securities Inc. operates as a mortgage real estate investment trust. The company was founded in 2008 and is based in Atlanta, Georgia.
No comments:
Post a Comment